Lin Y, Li X, Zhao H, Chen J, Li J, Yan Y
J Exerc Sci Fit. 2024; 22(2):168-177.
PMID: 38464601
PMC: 10920736.
DOI: 10.1016/j.jesf.2024.02.006.
Ng J, Than W, Szeto C
Front Nephrol. 2023; 2:880097.
PMID: 37675033
PMC: 10479638.
DOI: 10.3389/fneph.2022.880097.
Panda S, Nayak A, Shah S, Aich P
Metabolites. 2023; 13(4).
PMID: 37110147
PMC: 10144251.
DOI: 10.3390/metabo13040488.
Hu X, Xia K, Dai M, Han X, Yuan P, Liu J
NPJ Biofilms Microbiomes. 2023; 9(1):19.
PMID: 37029135
PMC: 10081985.
DOI: 10.1038/s41522-023-00386-4.
Lappa D, Meijnikman A, Krautkramer K, Olsson L, Aydin O, van Rijswijk A
PLoS One. 2023; 18(3):e0279335.
PMID: 36862673
PMC: 9980823.
DOI: 10.1371/journal.pone.0279335.
A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects.
Ben Othman R, Ben Amor N, Mahjoub F, Berriche O, El Ghali C, Gamoudi A
Endocrinol Diabetes Metab. 2023; 6(2):e402.
PMID: 36606510
PMC: 10000630.
DOI: 10.1002/edm2.402.
The effects of probiotic administration on patients with prediabetes: a meta-analysis and systematic review.
Li Y, Wu Y, Wu L, Qin L, Liu T
J Transl Med. 2022; 20(1):498.
PMID: 36324119
PMC: 9632036.
DOI: 10.1186/s12967-022-03695-y.
Polysaccharide from Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut-Liver Axis.
Li L, Lan X, Peng X, Shi S, Zhao Y, Liu W
Int J Mol Sci. 2022; 23(18).
PMID: 36142520
PMC: 9505563.
DOI: 10.3390/ijms231810620.
Analysis of the Relationship between Gut Flora Levels in Childhood Obese Population and Normal Healthy Population Based on Machine Learning.
Feng Y, Si X, Zhu R, Chen J, Zhao W, Wang Q
Comput Math Methods Med. 2022; 2022:6860940.
PMID: 36072769
PMC: 9441368.
DOI: 10.1155/2022/6860940.
Regulation of a High-Iron Diet on Lipid Metabolism and Gut Microbiota in Mice.
Xiong Q, Zhao J, Tian C, Ma W, Miao L, Liang L
Animals (Basel). 2022; 12(16).
PMID: 36009656
PMC: 9405328.
DOI: 10.3390/ani12162063.
Butyrate to combat obesity and obesity-associated metabolic disorders: Current status and future implications for therapeutic use.
van Deuren T, Blaak E, Canfora E
Obes Rev. 2022; 23(10):e13498.
PMID: 35856338
PMC: 9541926.
DOI: 10.1111/obr.13498.
Ferulic acid improves intestinal barrier function through altering gut microbiota composition in high-fat diet-induced mice.
Tian B, Geng Y, Wang P, Cai M, Neng J, Hu J
Eur J Nutr. 2022; 61(7):3767-3783.
PMID: 35732902
DOI: 10.1007/s00394-022-02927-7.
The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass.
Debedat J, Le Roy T, Voland L, Belda E, Alili R, Adriouch S
Gut Microbes. 2022; 14(1):2050635.
PMID: 35435140
PMC: 9037437.
DOI: 10.1080/19490976.2022.2050635.
What Is the Role of Gut Microbiota in Obesity Prevalence? A Few Words about Gut Microbiota and Its Association with Obesity and Related Diseases.
Tokarek J, Gadzinowska J, Mlynarska E, Franczyk B, Rysz J
Microorganisms. 2022; 10(1).
PMID: 35056501
PMC: 8777962.
DOI: 10.3390/microorganisms10010052.
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives.
Barone M, DAmico F, Fabbrini M, Rampelli S, Brigidi P, Turroni S
World J Gastroenterol. 2021; 27(41):7041-7064.
PMID: 34887627
PMC: 8613651.
DOI: 10.3748/wjg.v27.i41.7041.
Gut microbiome alpha-diversity is not a marker of Parkinson's disease and multiple sclerosis.
Plassais J, Gbikpi-Benissan G, Figarol M, Scheperjans F, Gorochov G, Derkinderen P
Brain Commun. 2021; 3(2):fcab113.
PMID: 34704023
PMC: 8195527.
DOI: 10.1093/braincomms/fcab113.
Predictive Value of Gut Microbiome for Cognitive Impairment in Patients with Hypertension.
Lu S, Shao L, Zhang Y, Yang Y, Wang Z, Zhang B
Dis Markers. 2021; 2021:1683981.
PMID: 34659587
PMC: 8514967.
DOI: 10.1155/2021/1683981.
Antidiabetic Function of MF423-Fermented Rice Bran and Its Effect on Gut Microbiota Structure in Type 2 Diabetic Mice.
Ai X, Wu C, Yin T, Zhur O, Liu C, Yan X
Front Microbiol. 2021; 12:682290.
PMID: 34248898
PMC: 8266379.
DOI: 10.3389/fmicb.2021.682290.
The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites.
Meng Q, Ma M, Zhang W, Bi Y, Cheng P, Yu X
Gut Microbes. 2021; 13(1):1-27.
PMID: 33691599
PMC: 7954427.
DOI: 10.1080/19490976.2021.1880220.
Enteric Phageome Alterations in Patients With Type 2 Diabetes.
Chen Q, Ma X, Li C, Shen Y, Zhu W, Zhang Y
Front Cell Infect Microbiol. 2021; 10:575084.
PMID: 33552999
PMC: 7862107.
DOI: 10.3389/fcimb.2020.575084.